𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gefitinib does not improve survival when combined with paclitaxel and carboplatin chemotherapy in people with advanced non-small-cell lung cancer: Abstracted from: Herbst RS, Giaccone G, Schiller JH et al. Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial – INTACT 2. J Clin Oncol 2004;22:785–94.

✍ Scribed by W.K. (Bill) Evans

Book ID
116394917
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
245 KB
Volume
30
Category
Article
ISSN
0305-7372

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel plus cisplatin is as effectiv
Paclitaxel plus cisplatin is as effective as regimens containing gemcitabine in people with advanced non-small cell lung cancer: Abstracted from: Smit EF, van Meerbeeck JP, Lianes P, et al. Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group-EORTC 08975. J Clin Oncol 2003;21:3909–17.
✍ Sarah Danson 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 163 KB